Genentech
Phesgo
Manufacturer:
Genentech
Name:
Phesgo
HCPCS Code Descriptor:
Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
Category:
J Code
HCPCS:
J9316
NDC(s):
50242-0260-01, 50242-0245-01
Primary Type:
Oncology
Generic/Specialty Status:
Single-Source
Route of Administration:
Subcutaneous
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
Phesgo is an Oncology drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J9316 is aligned to the drug Phesgo.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/21
HCPCS Effective Date:
1/1/21
HCPCS Short Description:
Pertuzu, trastuzu, 10 mg
Billing and Coding Guide:
https://www.phesgo-hcp.com/content/dam/gene/phesgo-hcp/pdfs/phesgo-coding-and-reimbursement-guide.pdf
Patient Assistance:
https://www.gene.com/patients/patient-foundation